Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

15.29
+0.40002.69%
Post-market: 15.21-0.0799-0.52%19:40 EDT
Volume:5.40M
Turnover:81.85M
Market Cap:1.50B
PE:-2.62
High:15.52
Open:14.79
Low:14.43
Close:14.89
52wk High:39.89
52wk Low:12.73
Shares:98.32M
Float Shares:80.72M
Volume Ratio:1.30
T/O Rate:6.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8279
EPS(LYR):-5.8316
ROE:-608.47%
ROA:-24.22%
PB:-5.17
PE(LYR):-2.62

Loading ...

Ultragenyx price target raised to $39 from $37 at Canaccord

TIPRANKS
·
Sep 18

Ultragenyx Pharma Price Target Raised to $39.00/Share from $33.00 by Cantor Fitzgerald

Dow Jones
·
Sep 18

Stocks to Watch: Xenon Pharmaceuticals, Ultragenyx Pharmaceutical, BRT Apartments

Dow Jones
·
Sep 18

Ultragenyx Pharmaceutical Exec Says U.S. Per Patient Wholesale Acquisition Cost for Fayuvi is Set at $3.95 Million - Conf Call

THOMSON REUTERS
·
Sep 18

Ultragenyx confirms FDA approval of Fayuvi

TIPRANKS
·
Sep 18

Ultragenyx Stock Jumps on Landmark FDA Approval

Dow Jones
·
Sep 18

Ultragenyx Pharmaceutical Rises After FDA Approves Fayuvi for Sanfilippo Syndrome Type A

Dow Jones
·
Sep 18

Ultragenyx Pharmaceutical - Fayuvi Expected to Ship to Qualified Treatment Centers Within 30-60 Days

THOMSON REUTERS
·
Sep 18

Ultragenyx Sets $3.95 Million Price for Rare Disease Gene Therapy

Reuters
·
Sep 18

US FDA Approves Ultragenyx's Gene Therapy for Rare Disorder

Reuters
·
Sep 18

FDA: Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A

THOMSON REUTERS
·
Sep 18

Ultragenyx call volume above normal and directionally bullish

TIPRANKS
·
Sep 17

Ultragenyx treatment of GNE myopathy granted orphan designation

TIPRANKS
·
Sep 15

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Intellia Therapeutics (NTLA) and Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Sep 08

Ultragenyx price target lowered to $32 from $43 at Barclays

TIPRANKS
·
Sep 04

Sector Update: Healthcare Stocks Higher Thursday Afternoon

MT Newswires Live
·
Sep 04

Nvidia, Tesla, Robinhood, Snowflake, Ultragenyx, Ciena, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 04

Ultragenyx downgraded to Equal Weight from Overweight at Morgan Stanley

TIPRANKS
·
Sep 04

Ultragenyx falls -44.0%

TIPRANKS
·
Sep 04

Ultragenyx Pharmaceutical Down over 45%, on Pace for Record Low Close and Record Percent Decrease

Dow Jones
·
Sep 03